Over 2,000 real rulings β analysed for what they mean to your team. Published every day.
Showing 1914 cases
Anonymous complaint alleged GSKβs SUMMIT study press release was misleading (use of βsurvivalβ, 12.2% lower risk of dying) and omitted the black…
A payer-targeted email highlighted a 29% allopurinol price rise and implied Adenuric could help manage long-term costs. PMCPA found the material misleading…
Daiichi Sankyoβs publicly accessible forum website synopsis for an βadvance budgetary notificationβ workshop about an unlicensed anticoagulant (edoxaban) was ruled insufficiently targeted,…
A βsafetyβ letter about Navelbine Oral dosing was ruled promotional. Missing prescribing info and AE reporting, an unqualified indication, and misleading/unsupported efficacy-survival…
An NHS chief pharmacist alleged a Strattera nurse speaker contract looked like inducement/seeding research and queried disclosure. PMCPA found misunderstanding from wording…
Public complaint about clinical trial transparency data. Panel found delayed disclosure for one UK-involved Mozobil trial (breach Clauses 9.1, 21.3). Renvela issues…
Anonymous complaint alleged excessive hospitality and poor rep conduct at a Novartis-sponsored restaurant meeting. Panel said costs/drinks were at the outer limits…
A sevoflurane packaging βdrop testβ leaflet was ruled promotional. It omitted the medicineβs cost, the mandatory adverse event reporting statement and the…
Anonymous complaint alleged GSK promoted an unlicensed malaria vaccine to the public via a Telegraph Online ad. PMCPA ruled the 30-second video…
Anonymous GP alleged an MSD representative brought her daughter to meetings. MSD found no record of any complaint. Panel said allegation not…
Anonymous complaint alleged industry-funded audits/training via a nurse-owned consultancy influenced prescribing in a CCG. Panel found no evidence to support inducement allegations;…
An ex-employee found a Relvar Ellipta cost calculator via search engines that appeared to lack PI, AE statement and black triangle. Panel…
Novo Nordiskβs Tresiba leavepiece overstated clamp-study variability data and visually exaggerated a nocturnal hypoglycaemia comparison. PMCPA ruled breaches of Clauses 7.2, 7.3,…
A hospital doctor couldnβt find working adverse event reporting or a Yellow Card link on Menariniβs website. Panel ruled breaches for missing…
Two HCPs alleged Servier sponsored a learned society weekend meeting at Windsor Castle. Servier showed it declined sponsorship due to venue risk…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week β free.